Treating asymptomatic aortic stenosis with TAVR linked to significant benefits

EARLY TAVR investigator Philippe Généreux, MD, announced his team’s findings in front of a packed audience at TCT 2024.

EARLY TAVR lead investigator Philippe Généreux, MD, announces his team’s findings in front of a packed audience at TCT 2024. Attendees cheered and roared with excitement as he revealed the study’s primary outcomes, an early sign that interventional cardiologists have been anticipating these results for quite some time. 

Attendees cheered as lead investigator Philippe Généreux, MD, shared his team's findings at TCT 2024. “A major reset in our approach to severe asymptomatic AS is now warranted,” one veteran cardiologist said about the data. “The concept of watchful waiting is no longer appropriate."